Pharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C3] in Mice and Primates

[1]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[2]  John Polich,et al.  Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates , 2014, Annals of neurology.

[3]  R. Mach,et al.  No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease , 2012, PloS one.

[4]  C. Xiong,et al.  A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice , 2008, Neurobiology of Aging.

[5]  C. Xiong,et al.  Gender differences in free radical homeostasis during aging: shorter‐lived female C57BL6 mice have increased oxidative stress , 2006, Aging cell.

[6]  C. Epstein,et al.  A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. , 2004, Free radical biology & medicine.

[7]  L. Ho,et al.  Local carboxyfullerene protects cortical infarction in rat brain , 2002, Neuroscience Research.

[8]  K. O’Malley,et al.  Fullerene-based antioxidants and neurodegenerative disorders. , 2001, Parkinsonism & related disorders.

[9]  L. Dugan,et al.  Superoxide stress identifies neurons at risk in a model of ataxia‐telangiectasia , 2001, Annals of neurology.

[10]  A. Majid,et al.  Differences in Vulnerability to Permanent Focal Cerebral Ischemia Among 3 Common Mouse Strains , 2000, Stroke.

[11]  S. Kennel,et al.  In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. O’Malley,et al.  Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons , 1999, The Journal of Neuroscience.

[13]  B. Erlanger,et al.  Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Chou,et al.  Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene. , 1998, European journal of biochemistry.

[15]  Shen,et al.  Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Wudl,et al.  Pharmacokinetics of a water-soluble fullerene in rats , 1996, Antimicrobial agents and chemotherapy.

[17]  D. Choi,et al.  Buckminsterfullerenol Free Radical Scavengers Reduce Excitotoxic and Apoptotic Death of Cultured Cortical Neurons , 1996, Neurobiology of Disease.

[18]  E. Nakamura,et al.  In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. , 1995, Chemistry & biology.

[19]  Y. Nagai,et al.  Comparative haematological and plasma chemistry values in purpose-bred squirrel, cynomolgus and rhesus monkeys , 1994, Comparative Haematology International.

[20]  H. L. Wiener,et al.  Separation and determination of sertraline and its metabolite, desmethylsertraline, in mouse cerebral cortex by reversed-phase high-performance liquid chromatography. , 1990, Journal of chromatography.

[21]  L. Tremaine,et al.  Characterization of a carbamic acid ester glucuronide of the secondary amine sertraline. , 1989, Drug metabolism and disposition: the biological fate of chemicals.